- Home
- STRO vs LAZR Comparison
STRO vs LAZR Comparison
Compare STRO & LAZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- LAZR
- Stock Information
- Founded
- STRO 2003
- LAZR 2012
- Country
- STRO United States
- LAZR United States
- Employees
- STRO N/A
- LAZR N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- LAZR Auto Parts:O.E.M.
- Sector
- STRO Health Care
- LAZR Consumer Discretionary
- Exchange
- STRO Nasdaq
- LAZR Nasdaq
- Market Cap
- STRO 77.7M
- LAZR 140.7M
- IPO Year
- STRO 2018
- LAZR N/A
- Fundamental
- Price
- STRO $0.78
- LAZR $2.75
- Analyst Decision
- STRO Hold
- LAZR Hold
- Analyst Count
- STRO 7
- LAZR 7
- Target Price
- STRO $3.97
- LAZR $37.83
- AVG Volume (30 Days)
- STRO 1.2M
- LAZR 2.8M
- Earning Date
- STRO 08-12-2025
- LAZR 08-12-2025
- Dividend Yield
- STRO N/A
- LAZR N/A
- EPS Growth
- STRO N/A
- LAZR N/A
- EPS
- STRO N/A
- LAZR N/A
- Revenue
- STRO $66,434,000.00
- LAZR $73,313,000.00
- Revenue This Year
- STRO N/A
- LAZR $16.78
- Revenue Next Year
- STRO N/A
- LAZR $29.92
- P/E Ratio
- STRO N/A
- LAZR N/A
- Revenue Growth
- STRO N/A
- LAZR N/A
- 52 Week Low
- STRO $0.52
- LAZR $2.52
- 52 Week High
- STRO $5.17
- LAZR $32.70
- Technical
- Relative Strength Index (RSI)
- STRO 48.21
- LAZR 39.93
- Support Level
- STRO $0.73
- LAZR $2.81
- Resistance Level
- STRO $0.79
- LAZR $3.14
- Average True Range (ATR)
- STRO 0.06
- LAZR 0.17
- MACD
- STRO 0.01
- LAZR 0.04
- Stochastic Oscillator
- STRO 56.00
- LAZR 40.80
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About LAZR Luminar Technologies Inc.
Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and Advanced Technologies and Services. The majority of its revenue is generated from the Autonomy Solutions segment, which engages in the design, manufacturing, and sale of LiDAR sensors, catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries. The Advanced Technologies and Services segment provides semiconductors and related components, as well as design, test, and consulting services to the Autonomy Solutions segment and various third-party customers. Geographically, the company derives its key revenue from North America.